# Study of TCM Syndrome of Hepatocellular Carcinoma and Colorectal Cancer Based on System Science

> **NCT03189992** · PHASE1 · UNKNOWN · sponsor: **Shanghai University of Traditional Chinese Medicine** · enrollment: 320 (estimated)

## Conditions studied

- Malignant Tumor of Small Intestine Metastatic to Liver

## Interventions

- **DRUG:** Bushen-Jianpi Dedoction
- **DRUG:** cinobufotalin injection

## Key facts

- **NCT ID:** NCT03189992
- **Lead sponsor:** Shanghai University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2017-08
- **Final completion:** 2018-12
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2017-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03189992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03189992, "Study of TCM Syndrome of Hepatocellular Carcinoma and Colorectal Cancer Based on System Science". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03189992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*